(2026). Cagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: A systematic review and meta-analysis. Journal of Diabetes and Metabolic Disorders.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Cagrilintide and CagriSema for Weight Reduction and Metabolic Risk Modification in Overweight or Obesity: A Systematic Review and Meta-analysis."
Journal of Diabetes and Metabolic Disorders 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Cagrilintide and CagriSema for Weight Reduction and Metabolic Risk Modification in Overweight or Obesity: A Systematic Review and Meta-analysis."
Journal of Diabetes and Metabolic Disorders, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.